In terms of the authorizations in Canada for opioids, they're a marketed product. So if there was a situation where there was an adulteration or contamination, we would embark upon an assessment to see what the risks associated with that would be. Then we would look at whether or not there were compliance and enforcement actions that we would need to take.
There is a whole suite of compliance and enforcement actions that we can take, such as recalling the product, changing labels, etc.